安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Pharmacovigilance - PAHO WHO | Pan American Health Organization
Medicines and vaccines have transformed the prevention and treatment of diseases over time In addition to their benefits, they can have side effects, some of which may be undesirable and or unexpected Pharmacovigilance is the science and the activities related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine or vaccine related problem
- Pharmacovigilance training at WHO - PAHO
Pharmacovigilance Inspections Training Course The training course aims to provide an introduction to the organization, planning, conduct, reporting and follow-up of pharmacovigilance inspections, to regulatory authority personnel who will be involved or who are already involved in pharmacovigilance inspections
- WHO PHARMACOVIGILANCE INDICATORS: A PRACTICAL MANUAL FOR THE ASSESSMENT . . .
The indicators are further classified as either core or complementary The core indicators address important pharmacovigilance issues and provide information which should be readily available to enable determination of the pharmacovigilance status of the setting and allow for comparison with other settings 1 The complementary indicators are
- PAHO calls for strengthened pharmacovigilance following reports of . . .
Washington, DC, March 3, 2026 (PAHO) — The Pan American Health Organization (PAHO) urged countries in the Region of the Americas to strengthen monitoring and ensure the appropriate use of glucagon-like peptide-1 receptor agonist (GLP-1) medicines, in light of increasing reports of adverse events associated with their misuse
- New regulations, policies and technological advances in . . .
Bogotá, October 29, 2024 (PAHO) - The Pan American Health Organization and the National Institute for Drug and Food Surveillance (Invima) of Colombia held the XIX International Pharmacovigilance Meeting and the face-to-face regional meeting of pharmacovigilance focal points (FV) of the Americas The event addressed and discussed the challenges and opportunities in pharmacovigilance, the most
- Risk Management Plans and Periodic Safety Update Reports
The overall aim of risk management is to ensure that the benefits of a particular medicinal product exceed the risks by the greatest achievable margin for both the individual patient and the target population; in other words, to optimize the use of the drug (2) The fundamentals of a risk management plan are based on proactive pharmacovigilance planning, by: Anticipating the risks of medicines
- Documents - PAHO WHO | Pan American Health Organization
Pharmacovigilance Documents Show filters 2 Mar 2023 WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-fifth report
- Guyana Advances Toward an Integrated National Pharmacovigilance . . .
Georgetown, July 21, 2025 – Guyana is moving forward in the implementation of VigiFlow as its national pharmacovigilance platform with support from the Pan American Health Organization (PAHO WHO) This decision will enable the health system to consolidate, analyze, and respond more efficiently to adverse events related to medicines and vaccines, thereby strengthening patient safety
|
|
|